–Up to 68.2% mean relative reduction in liver fat content from baseline among biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients receiving 12-week treatment of ASC41 –Significant and clinically meaningful reductions in liver fat, alanine aminotransferase…

GRESHAM, Oregon et TOKYO, 11 juin 2024 /PRNewswire/ — Element Six (E6) et , tous deux leaders mondiaux dans le domaine des matériaux de pointe haute performance, ont annoncé aujourd’hui une collaboration stratégique pour fournir le diamant synthétique monocristallin (SC) à l’échelle de…

GRESHAM, Oregon und TOKYO, 11. Juni 2024 /PRNewswire/ — Element Six (E6) und Orbray, beides weltweit führende Unternehmen im Bereich hochleistungsfähiger fortschrittlicher Materialien, gaben heute eine strategische Zusammenarbeit bekannt, um den weltweit hochwertigsten synthetischen…

SHANGHAI and HEIDELBERG, Germany, June 10, 2024 /PRNewswire/ — Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its NTSR1-targeting RDC program FL-091 in an oral presentation at the 2024 SNMMI (The Society of Nuclear…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.